This is a past event. Registration is closed. View other Asia Pacific Glaucoma Society – APGS events.
Save the date
Save the dateNovember 22, 202318:00 - 19:30 GMT+8
Organizer
Organizer
Organizer: Asia Pacific Glaucoma Society – APGS
Contact Person: APGS Secretariat
Email: info@apglaucomasociety.org
Event Details
Event Details
Please note that this program is exclusively designed for early-stage glaucoma experts under the age of 40.
Discover the intricacies of "Ocular Surface Disease (OSD) in Glaucoma Patients" in Chapter 6 of the Young Glaucoma Experts Program. OSD often remains a neglected facet of patient care, despite its pivotal role in the well-being of glaucoma patients. Acknowledging and effectively addressing OSD is a critical imperative for healthcare professionals, as it not only guarantees patient comfort and adherence to glaucoma treatment but also mitigates the potential side effects that can result from prolonged use of eye drops.
Our panel of experts will delve into 3 real-world case studies, sharing insights on how to diagnose, manage, and treat OSD in glaucoma patients effectively. This webinar is an absolute necessity for emerging glaucoma professionals who are eager to deepen their knowledge in this field, as it promises to equip them with the skills and expertise to make a genuine difference in patient care.
More about Young Glaucoma Experts Program
This program is, initiated by The Asia-Pacific Glaucoma Society, designed for early-career glaucoma professionals who aspire to become leaders in the field. Don't miss out on this opportunity to enhance your knowledge and understanding.
Being a part of the program, you will gain access to a diverse range of resources and tools, including:
- Webinars and lectures featuring renowned experts in the field of glaucoma
- Mentorship in the latest diagnostic and treatment techniques
- Networking opportunities with fellow professionals and mentors
- Opportunities to present research and collaborate on projects with other members of the program
- With the support of our experienced faculty, you will develop the skills and knowledge necessary to advance your career and make a meaningful impact in the lives of patients with glaucoma.
Agenda
Agenda
17:45 - 18:00
Opening Video
Opening Video
18:00 - 18:05
Introduction by the Moderator
Introduction by the Moderator
18:05 - 18:20
Part 1 : Lecture Based
Part 1 : Lecture Based
18:20 - 18:35
Discussion and Q&A
18:35 - 18:40
Case 1: Impact beyond OSD problems; leading to reduce treatment success outcomes
Case 1: Impact beyond OSD problems; leading to reduce treatment success outcomes
This case series will highlight how ocular surface disease(OSD) in glaucoma patients negatively impact management and hinders treatment success. Periorbital changes and tight lids make intraocular pressure measurement difficult,sometimes inaccurate. Ocular surface changes and dry eye disease due to long term use of topical glaucoma medication affects the quality of diagnostic tests. They can also make patients symptomatic and affect medication adherence. Subconjunctival inflammation produced by ...This case series will highlight how ocular surface disease(OSD) in glaucoma patients negatively impact management and hinders treatment success. Periorbital changes and tight lids make intraocular pressure measurement difficult,sometimes inaccurate. Ocular surface changes and dry eye disease due to long term use of topical glaucoma medication affects the quality of diagnostic tests. They can also make patients symptomatic and affect medication adherence. Subconjunctival inflammation produced by these medications also affect the success of glaucoma filtering surgeries. These case examples will highlight that it is imperative for the clinician to recognise and treat OSD early for better treatment outcomes.view more18:40 - 18:50
Case 1 Discussion
18:50 - 18:55
Case 2: Impact of OSD and MGD to increase risk of postoperative complications
Case 2: Impact of OSD and MGD to increase risk of postoperative complications
48-year-old gentleman, Mr T, an active smoker has DM and uncontrolled advance POAG and planned for left eye filtration surgery. Pre-operatively, noted Mr T had MGD, OSD with allergic component. He was started on treatment & subsequently underwent an uneventful LE Preserflo implantation when his MGD & OSD improved. One month post-op, we noted localised injected bleb with blepharitis and high IOP (26mmHg). 5-FU injections was given thrice and but his bleb condition persisted, hence we proceeded wi...48-year-old gentleman, Mr T, an active smoker has DM and uncontrolled advance POAG and planned for left eye filtration surgery. Pre-operatively, noted Mr T had MGD, OSD with allergic component. He was started on treatment & subsequently underwent an uneventful LE Preserflo implantation when his MGD & OSD improved. One month post-op, we noted localised injected bleb with blepharitis and high IOP (26mmHg). 5-FU injections was given thrice and but his bleb condition persisted, hence we proceeded with needling. Post-needling his IOP came down to 7mmHg but only lasted about a month. His conjunctival is still mildly hyperemic with OSD but improved MGD. He was advised for repeat needling.view more18:55 - 19:05
Case 2 Discussion
19:05 - 19:10
Case 3: Improving Surgical Outcomes with Preservative-free medications
Case 3: Improving Surgical Outcomes with Preservative-free medications
This case demonstrates the use of preservative-free medications to decrease conjunctival inflammation and optimize the surgical site prior to trabeculectomy.19:10 - 19:20
Case 3 Discussion
19:20 - 19:30
QnA Session
QnA Session
Speakers
Speakers
Sponsors and Partners
Sponsors and Partners
Organizer
Sponsor
Santen is an eye health company with a history of more than 130 years. Since its foundation, Santen has been committed to providing products and services that significantly contribute to meeting patients' needs.
Community
Community
Connect with 342 people attending this event